Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-12

Clinical Trial Update: Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease [NA]

View source ↗

Summary

Feasibility and preliminary effects study of MR-005 in individuals with Parkinson disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MR-005

Snippet

Sponsor: MedRhythms, Inc. | Conditions: Parkinson Disease | NA | Status: COMPLETED | Results posted: 2023-12-12